The activation of these pathways in SSc dermal fibroblasts, in part as a result of excessive TGF-β/SMAD signalling, is necessary for CLIC4 upregulation and the consequent α-SMA expression. The gene discussed is TGFB1; the disease is systemic sclerosis.